Mitochondrial Diseases Part III

Therapeutic interventions in mouse models of OXPHOS deficiencies

Susana Peralta, Alessandra Torraco, Luisa Iommarini, Francisca Diaz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalMitochondrion
Volume23
DOIs
StatePublished - 2015

Fingerprint

Mitochondrial Diseases
Oxidative Phosphorylation
Action Potentials
Therapeutics
Pathology
Enzymes

Keywords

  • Mitochondria
  • Mitochondrial diseases
  • Mouse models
  • Oxidative phosphorylation
  • OXPHOS

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine

Cite this

Mitochondrial Diseases Part III : Therapeutic interventions in mouse models of OXPHOS deficiencies. / Peralta, Susana; Torraco, Alessandra; Iommarini, Luisa; Diaz, Francisca.

In: Mitochondrion, Vol. 23, 2015, p. 71-80.

Research output: Contribution to journalArticle

Peralta, Susana ; Torraco, Alessandra ; Iommarini, Luisa ; Diaz, Francisca. / Mitochondrial Diseases Part III : Therapeutic interventions in mouse models of OXPHOS deficiencies. In: Mitochondrion. 2015 ; Vol. 23. pp. 71-80.
@article{58c8f417979540bcabb9a16409bb7ef2,
title = "Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies",
abstract = "Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications.",
keywords = "Mitochondria, Mitochondrial diseases, Mouse models, Oxidative phosphorylation, OXPHOS",
author = "Susana Peralta and Alessandra Torraco and Luisa Iommarini and Francisca Diaz",
year = "2015",
doi = "10.1016/j.mito.2015.01.007",
language = "English (US)",
volume = "23",
pages = "71--80",
journal = "Mitochondrion",
issn = "1567-7249",
publisher = "Elsevier",

}

TY - JOUR

T1 - Mitochondrial Diseases Part III

T2 - Therapeutic interventions in mouse models of OXPHOS deficiencies

AU - Peralta, Susana

AU - Torraco, Alessandra

AU - Iommarini, Luisa

AU - Diaz, Francisca

PY - 2015

Y1 - 2015

N2 - Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications.

AB - Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications.

KW - Mitochondria

KW - Mitochondrial diseases

KW - Mouse models

KW - Oxidative phosphorylation

KW - OXPHOS

UR - http://www.scopus.com/inward/record.url?scp=84937634662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937634662&partnerID=8YFLogxK

U2 - 10.1016/j.mito.2015.01.007

DO - 10.1016/j.mito.2015.01.007

M3 - Article

VL - 23

SP - 71

EP - 80

JO - Mitochondrion

JF - Mitochondrion

SN - 1567-7249

ER -